14-20144219-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004724.2(OR4N5):c.484C>T(p.Leu162Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000861 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004724.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4N5 | NM_001004724.2 | c.484C>T | p.Leu162Phe | missense_variant | 3/3 | ENST00000641086.1 | NP_001004724.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4N5 | ENST00000641086.1 | c.484C>T | p.Leu162Phe | missense_variant | 3/3 | NM_001004724.2 | ENSP00000493307.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250938Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135590
GnomAD4 exome AF: 0.0000903 AC: 132AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.0000825 AC XY: 60AN XY: 727214
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2023 | The c.484C>T (p.L162F) alteration is located in exon 1 (coding exon 1) of the OR4N5 gene. This alteration results from a C to T substitution at nucleotide position 484, causing the leucine (L) at amino acid position 162 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at